• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA Lifts Hold on Mersana’s Antibody-Drug Conjugate Following Patient Death

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 02, 2023 at 12:22: PM
via The FDA has lifted its full clinical hold on Mersana Therapeutics’ Phase I study of XMT-2056, its investigational STING-directed antibody-drug conjugate, the company announced Tuesday.

article source
 

<



Similar threads

cafead
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor
Replies
0
Views
6
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA lifts partial clinical hold on Rezolute&#039;s low blood sugar treatment
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold
Replies
0
Views
27
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Iovance receives more good news as FDA lifts hold on lung cancer cell therapy trial
Replies
0
Views
126
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA lifts two-year clinical hold on CytoDyn’s HIV trial
Replies
0
Views
106
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote